ReferIndia News Aarti Pharmalabs: Can its CDMO bet revive growth after a weak year?

ReferIndia News

Need a website for your NGO?

Build trust and reach more donors—FreeNGO creates powerful websites tailored for your cause.

Contact Now
News Image

Aarti Pharmalabs: Can its CDMO bet revive growth after a weak year?

Published on: July 2, 2026, 6:42 a.m. | Source: The Indian Express

A caffeine giant, a growing CDMO business, and a recovering API segment. Can Aarti Pharmalabs convert a Rs 1,300+ crore capex cycle into a compounding pharma platform?

Checkout more news
Ad Banner

✅ Secure, cloud-based clinic management software

Manage digital prescriptions, appointments, patient records, billing, files, and reports — everything your clinic needs in one powerful platform.

Know more
ReferIndia News contact